| Revenue | DKK -591K | -35% |
| EBITDA | DKK -1,5M | +34% |
| Net profit | DKK -1,5M | +32% |
| Total assets | DKK 1,4M | -9% |
| Equity | DKK -4,7M | -47% |
| Employees | 5 | — |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | -595 | -930 | -912 | -591 |
| Staff expenses | -235 | -769 | -1.313 | -886 |
| EBITDA | -831 | -1.699 | -2.225 | -1.477 |
| Depreciation & amort. | -0 | -0 | -0 | -23 |
| EBIT | -831 | -1.699 | -2.225 | -1.501 |
| Net financials | -10 | -5 | -4 | -5 |
| Profit before tax | -841 | -1.704 | -2.229 | -1.505 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | -841 | -1.704 | -2.229 | -1.505 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1.449 | 917 | 1.562 | 1.429 |
| Equity | 970 | -940 | -3.169 | -4.674 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 478 | 1.857 | 4.731 | 6.103 |
| Total debt | 478 | 1.857 | 4.731 | 6.103 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NR Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lucia-Holding ApS | Company | 90.0% | 90.0% | 2021 |
DERMA PHARM A/S | Company | 10.0% | 10.0% | 2021 |
| Person | Role here | Other companies |
|---|---|---|
| Nanna Rebecca Kirkebjerg | Management | 0 companies |
| Søren Bjørrild Bregendal | Board of Directors | 0 companies |
| Mikkel Egelund Jensen | Board of Directors | 0 companies |
| Mia Therese Wagner | Board of Directors | 0 companies |
| Anne Stampe Olesen | Board of Directors | 0 companies |
| Christian Gerhard Bøving | Board of Directors | 0 companies |